152 related articles for article (PubMed ID: 3607369)
1. Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.
Duncker DJ; Hartog JM; Levinsky L; Verdouw PD
Br J Pharmacol; 1987 Jul; 91(3):609-15. PubMed ID: 3607369
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of UD-CG 212 CL, a metabolite of pimobendan, in anaesthetized pigs.
Verdouw PD; Levinsky L; Duncker DJ; Rutteman AM; Saxena PR
Eur J Pharmacol; 1987 Jun; 137(2-3):219-26. PubMed ID: 2886352
[TBL] [Abstract][Full Text] [Related]
3. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
Berger C; Meyer W; Scholz H; Starbatty J
Arzneimittelforschung; 1985; 35(11):1668-73. PubMed ID: 2418846
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties.
Verdouw PD; Hartog JM; Duncker DJ; Roth W; Saxena PR
Eur J Pharmacol; 1986 Jul; 126(1-2):21-30. PubMed ID: 2875884
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of intravenous UD-CG 115 BS (pimobendan) on the cardiovascular system and left ventricular pump function.
Permanetter B; Sebening H; Hartmann F; Klein G
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S36-40. PubMed ID: 2478790
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic profile of the cardiotonic agent pimobendan.
van Meel JC; Diederen W
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
van Woerkens LJ; van der Giessen WJ; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
Baumann G; Ningel K; Permanetter B
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
[TBL] [Abstract][Full Text] [Related]
9. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
Endoh M; Shibasaki T; Satoh H; Norota I; Ishihata A
J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
von Meel JC
Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
[TBL] [Abstract][Full Text] [Related]
12. Positive chronotropic and inotropic effects of pimobendan (UD-CG 115 BS) in isolated, cross-circulated canine heart preparations.
Furukawa Y; Akahane K; Ogiwara Y; Haniuda M; Chiba S
Arch Int Pharmacodyn Ther; 1989; 300():159-73. PubMed ID: 2575887
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
Westfall MV; Wahler GM; Fujino K; Solaro RJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):58-63. PubMed ID: 1346167
[TBL] [Abstract][Full Text] [Related]
14. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
[TBL] [Abstract][Full Text] [Related]
15. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
Pouleur H; Hanet C; Schröder E; Col J; Van Mechelen H; Etienne J; Rousseau MF
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S18-22. PubMed ID: 2478787
[TBL] [Abstract][Full Text] [Related]
16. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
17. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties.
Mochizuki N; Uchida S; Miyata H
J Cardiovasc Pharmacol; 1993 Jun; 21(6):983-95. PubMed ID: 7687727
[TBL] [Abstract][Full Text] [Related]
19. Decrease in Ca(2+)-sensitizing effect of UD-CG 212 Cl, a metabolite of pimobendan, under acidotic condition in canine ventricular myocardium.
Takahashi R; Shimazaki Y; Endoh M
J Pharmacol Exp Ther; 2001 Sep; 298(3):1060-6. PubMed ID: 11504803
[TBL] [Abstract][Full Text] [Related]
20. Increase in myofibrillar Ca2+ sensitivity induced by UD-CG 212 Cl, an active metabolite of pimobendan, in canine ventricular myocardium.
Takahashi R; Endoh M
J Cardiovasc Pharmacol; 2001 Feb; 37(2):209-18. PubMed ID: 11210003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
